NEU 0.35% $19.97 neuren pharmaceuticals limited

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-138

  1. 16 Posts.
    lightbulb Created with Sketch. 16
    A great summary of NEU on 'The Call' today with respect to this company's future direction.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.